These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 9422110

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Our first experience of transfusion support in allogenic bone marrow transplantations.
    Fregatova L, Volkova O, Platonova G, Afanasiev B.
    Beitr Infusionsther Transfusionsmed; 1994; 32():445-7. PubMed ID: 9422124
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD, Stussi G, Passweg JR, Loberiza FR, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringdén O, Barrett AJ, GVHD Working Committee of Center for International Blood and Marrow Transplant Research.
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [Abstract] [Full Text] [Related]

  • 6. Use of the gel test to follow up chimerism in ABO mismatched bone marrow transplantation patient: a case report.
    Lumkul R, Nathalang O, Arnutti P, Janyatham A, Torcharus K, Krutvecheo T, Sriphaisal T.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S311-6. PubMed ID: 16858974
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
    Tasaki T, Satoh S, Gotoh K, Fujii K, Sasaki S, Takadate J, Tachibana M, Ono Y, Ishida Y.
    Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
    [Abstract] [Full Text] [Related]

  • 9. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
    Schetelig J, Breitschaft A, Kröger N, Zabelina T, Ebell W, Bornhäuser M, Haack A, Ehninger G, Salama A, Siegert W, Cooperative Transplantations Study Group.
    Transfusion; 2005 May; 45(5):779-87. PubMed ID: 15847669
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Immunization against blood group antigens by allogeneic bone transplantation].
    Knaepler H, Ascherl R, Kretschmer V.
    Chirurg; 1990 Nov; 61(11):830-2. PubMed ID: 2126504
    [Abstract] [Full Text] [Related]

  • 12. Medicolegal assessment of blood transfusion errors--an interdisciplinary challenge.
    Padosch SA, Schmidt PH, Pedal I, Franchy C, Hoch J, Madea B.
    Forensic Sci Int; 2007 Oct 02; 172(1):40-8. PubMed ID: 17222999
    [Abstract] [Full Text] [Related]

  • 13. [ABO-incompatible bone marrow transplantation; removal of red blood cells from donor marrow by using Hemonetics model 30 blood cell separator].
    Kai S, Ifuku H, Ohe Y, Maeda K, Hara H, Nagai K, Shinohara Y, Misawa M, Kanamaru A.
    Rinsho Ketsueki; 1986 Jan 02; 27(1):22-9. PubMed ID: 3520044
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow.
    Ho WG, Champlin RE, Feig SA, Gale RP.
    Br J Haematol; 1984 May 02; 57(1):155-62. PubMed ID: 6372850
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Suitability of monoclonal test sera for determination of blood group markers in positive direct Coombs test].
    Strobel E, Wüllenweber J.
    Infusionsther Transfusionsmed; 1995 Apr 02; 22(2):117-27. PubMed ID: 7787405
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Monoclonal blood group antibodies.
    Voak D.
    Beitr Infusionsther; 1989 Apr 02; 24():200-13. PubMed ID: 2481540
    [Abstract] [Full Text] [Related]

  • 20. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Apr 02; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.